Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2024-05-20 00:00:00 ET · period of report 2024-05-16 · accession 0001104659-24-063455 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-20 | 2024-05-16 | FBIO | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | P - Purchase | $1.76 | +10.0K | 2.87M | +0.3% | +$17.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK, PAR VALUE $0.001 | 2024-05-16 | P | A | 10,000 | $1.76 | 2,873,905 | D | — | — |